Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism
about
Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects.Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response.Comparative metabolism of tramadol and tapentadol: a toxicological perspective.Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.Review of Opioid Pharmacogenetics and Considerations for Pain Management.Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial.Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!The pharmacogenetics of medications used in general anesthesia.Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6.Current Concepts in Methadone Metabolism and Transport.Effects of Genetic Polymorphisms of CYP2B6 on the Pharmacokinetics of Bupropion and Hydroxybupropion in Healthy Chinese Subjects.
P2860
Q38867027-D29FA349-8965-45C9-99F4-C25221C4B412Q38870014-A0BDA17C-759B-4A2A-B361-C15FC8AC78ECQ38942405-6CF694A5-8B54-4E96-8622-76014470EEBBQ39165843-32345BEC-E8B4-4E2B-8C1F-CC69594C901FQ39430407-8E9C0B8D-F960-4ED6-8CF6-68CA361EC800Q40129871-2C15F206-DFD8-4AAB-953F-34416FF16153Q40367486-266C5350-E974-47E5-AF19-19194C2E0433Q44811171-F35C9EF6-9D8C-4657-AD38-AEFAC3A0837BQ47213395-564E2321-757D-47C5-8D77-1C7C3436BA7DQ47727598-892B95F6-3A0A-4295-8C74-8989F81A0450Q48244859-6BD755F3-CA08-4230-AC8C-0943DC89A329Q49215469-E48403AB-5FFD-4FE3-97B2-6D35616F0827Q50682107-506F9436-779D-4402-B427-CEA63158716FQ55262171-2013B776-8910-4F4C-9000-43176FE1A66F
P2860
Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@ast
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@en
type
label
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@ast
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@en
prefLabel
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@ast
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@en
P2093
P2860
P1433
P1476
Methadone Pharmacogenetics: CY ...... ons, Clearance, and Metabolism
@en
P2093
Christina Friedel
Evan D Kharasch
Jane Blood
Karen J Regina
P2860
P304
P356
10.1097/ALN.0000000000000867
P407
P577
2015-09-19T00:00:00Z